CTCFL and cancer: As of July 2019, 382 of the 10,950 (3%) cancer samples profiled in cBioPortal [40] were found to have genetic changes in CTCFL, with amplification occurring most frequently (58%) in these patient samples (Additional file 1: Figure S1B-E).